[1] RENNER G. Small cell carcinoma of the head and neck:A review[J].Semin Oncol,2007,34(1):3-14. [2] FERLITO A, DEVANEY K O, RINALDO A.Neuroendocrine neoplasms of the larynx:advances in identification, understanding, and management[J].Oral Oncol, 2006, 42(8):770-788. [3] IQBAL M S, PALERI V, MOOR J, et al.Small cell neuroendocrine carcinoma of larynx:case series and literature review[J].J Laryngol Otol, 2015, 129(9):910-915. [4] HALMOS G B, VAN DER LAAN T P, VAN HEMEL B M, et al.Is human papillomavirus involved in laryngeal neuroendocrine carcinoma?[J].Eur Arch Otorhinolaryngol, 2013, 270(2):719-725. [5] GNEPP D R.Small cell neuroendocrine carcinoma of the larynx.A critical review of the literature[J].ORL J Otorhinolaryngol Relat Spec, 1991, 53(4):210-219. [6] FERLITO A, RINALDO A.Primary and secondary small cell neuroendocrine carcinoma of the larynx:a review[J].Head Neck, 2008, 30(4):518-524. [7] POINTER K B, KO H C, BROWER J V, et al.Small cell carcinoma of the head and neck:An analysis of the National Cancer Database[J].Oral Oncol, 2017, 69:92-98. [8] VAN DER LAAN T P, PLAAT B E, VAN DER LAAN B F, et al.Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx:A meta-analysis of 436 reported cases[J].Head Neck, 2015, 37(5):707-715. [9] SONE M, UCHIDA I, TOMINAGA M, et al.Small cell carcinoma of the larynx treated with irinotecan and cisplatin[J].Auris Nasus Larynx, 2006, 33(2):223-225. [10] LEE J M, LEE K B, NAM J H, et al.Prognostic factors in FIGO stage IB-ⅡA small cell neuroendocrine carcinoma of the uterine cervix treated surgically:results of a multi-center retrospective Korean study[J].Ann Oncol, 2008, 19(2):321-326. [11] BARKER J L Jr, GLISSON B S, GARDEN A S, et al.Management of nonsinonasal neuroendocrine carcinomas of the head and neck[J].Cancer, 2003, 98(11):2322-2328. [12] CICIN I, KARAGOL H, UZUNOGLU S, et al.Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma:A retrospective single-center study[J].Cancer, 2007, 110(5):1068-1076. [13] BRENNAN S M, GREGORY D L, STILLIE A, et al.Should extrapulmonary small cell cancer be managed like small cell lung cancer?[J].Cancer, 2010, 116(4):888-895. [14] GALANIS E, FRYTAK S, LLOYD R V.Extrapulmonary small cell carcinoma[J].Cancer, 1997, 79(9):1729-1736. [15] YAZICI O, OZDEMIR N Y, SENDUR M A, et al.Current approaches for prophylactic cranial irradiation in extrapulmonary small cell carcinoma[J].Curr Med Res Opin, 2014, 30(7):1327-1336. [16] TREMONT-LUKATS I W, BOBUSTUC G, LAGOS G K, et al.Brain metastasis from prostate carcinoma:The M.D.Anderson Cancer Center experience[J].Cancer, 2003, 98(2):363-368. [17] PAPANDREOU C N, DALIANI D D, THALL P F, et al.Results of a phase Ⅱ study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate[J].J Clin Oncol, 2002, 20(14):3072-3080. [18] ROSENTHAL D I, BARKER J L Jr, EI-NAGGAR A K, et al.Sinonasal malignancies with neuroendocrine differentiation:patterns of failure according to histologic phenotype[J].Cancer, 2004, 101(11):2567-2573. [19] SALHAB M, MIGDADY Y, DONAHUE M, et al.Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma:a single institution experience[J].J Immunother Cancer, 2018, 6(1):42. [20] HUSNAIN M, PARK W, RAMOS J C, et al.Complete response to ipilimumab and nivolumab therapy in a patient with extensive extrapulmonary high-grade small cell carcinoma of the pancreas and HIV infection[J].J Immunother Cancer, 2018, 6(1):66. |